BioMarin Pharmaceutical, Inc. (BMRN)
56.44
+1.77
(+3.24%)
USD |
NASDAQ |
Oct 20, 16:00
56.40
-0.04
(-0.07%)
After-Hours: 06:52
BioMarin Pharmaceutical Gross Profit (TTM) : 2.556B for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.556B |
| March 31, 2026 | 2.508B |
| December 31, 2025 | 2.510B |
| September 30, 2025 | 2.488B |
| June 30, 2025 | 2.395B |
| March 31, 2025 | 2.286B |
| December 31, 2024 | 2.216B |
| September 30, 2024 | 2.118B |
| June 30, 2024 | 2.015B |
| March 31, 2024 | 1.902B |
| December 31, 2023 | 1.842B |
| September 30, 2023 | 1.720B |
| June 30, 2023 | 1.632B |
| March 31, 2023 | 1.571B |
| December 31, 2022 | 1.501B |
| September 30, 2022 | 1.437B |
| June 30, 2022 | 1.369B |
| March 31, 2022 | 1.342B |
| December 31, 2021 | 1.314B |
| September 30, 2021 | 1.314B |
| June 30, 2021 | 1.292B |
| March 31, 2021 | 1.238B |
| December 31, 2020 | 1.253B |
| September 30, 2020 | 1.279B |
| June 30, 2020 | 1.354B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.339B |
| December 31, 2019 | 1.273B |
| September 30, 2019 | 1.208B |
| June 30, 2019 | 1.166B |
| March 31, 2019 | 1.164B |
| December 31, 2018 | 1.152B |
| September 30, 2018 | 1.156B |
| June 30, 2018 | 1.127B |
| March 31, 2018 | 1.090B |
| December 31, 2017 | 1.041B |
| September 30, 2017 | 995.28M |
| June 30, 2017 | 943.69M |
| March 31, 2017 | 940.37M |
| December 31, 2016 | 880.60M |
| September 30, 2016 | 829.15M |
| June 30, 2016 | 776.00M |
| March 31, 2016 | 731.83M |
| December 31, 2015 | 713.46M |
| September 30, 2015 | 719.55M |
| June 30, 2015 | 697.81M |
| March 31, 2015 | 653.19M |
| December 31, 2014 | 616.25M |
| September 30, 2014 | 546.92M |
| June 30, 2014 | 500.27M |
| March 31, 2014 | 443.30M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Ascendis Pharma A/S | 1.097B |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Cytokinetics, Inc. | 46.98M |